Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: For several decades, a myriad of factors have contributed to the inadequate diagnosis and management of depression in Parkinson's disease (PD), leaving up to 60% of significantly symptomatic patients untreated. Poor access to evidence‐based neuropsychiatric care is one major barrier to achieving optimal Parkinson's outcomes. Objective: The goal of this study was to compare the efficacy of individual Parkinson's‐informed, video‐to‐home cognitive‐behavioral therapy (experimental group), to clinic‐based treatment as usual (control group), for depression in PD. Method: Ninety United States military veterans with clinical diagnoses of both depression and PD were computer‐randomized (1:1) to either the experimental or control group; randomization was stratified by baseline antidepressant use and blind to all other baseline data. The acute treatment period spanned 10 weeks and was followed by a 6‐month extension phase. The Hamilton Depression Rating Scale was the a priori primary outcome. Depression treatment response was defined as a score ≤2 on the Clinical Global Impression Improvement Scale. All statistical analyses were intent to treat. Results: Video‐to‐home cognitive‐behavioral therapy outperformed clinic‐based treatment as usual across three separate depression measures (P < 0.001). Effects were observed at the end of acute treatment and maintained through 6‐month follow‐up. Number needed to treat (based on treatment response classification) was 2.5 with an absolute risk reduction of 40%. Conclusion: Video‐to‐home cognitive‐behavioral therapy may be an effective intervention to bypass access barriers to specialized, evidence‐based depression care in PD and to address the unmet neuropsychiatric treatment needs of the Parkinson's community. © 2021 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
A systematic review of prevalence studies of depression in Parkinson's disease
Reijnders, J. S. A. M., Ehrt, U., Weber, W. E. J., Aarsland, D., & Leentjens, A. F. G. (2008) · Movement Disorders · doi:10.1002/mds.21803 · Cited by 1,239
The Role of Common Factors in Psychotherapy Outcomes
Cuijpers, P., Reijnders, M., & Huibers, M. J. H. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095424 · Cited by 748 · cited 1×
“Third, it is not possible to fully disaggregate effects of this V-CBT intervention from nonspecific factors (eg, therapeutic relationship, attention) that contribute to all psychotherapy outcomes.(39) However, the marked, durable decline in depressive symptoms in the V-CBT group only—and the improvements in depression…”
BackgroundKanter, J. W., Mulick, P. S., Busch, A. M., Berlin, K. S., & Martell, C. R. (2007) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-006-9038-5 · Cited by 493
Freedland, K. E., Mohr, D. C., Davidson, K. W., & Schwartz, J. E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318218e1fb · Cited by 369
A randomized trial of telemedicine-based collaborative care for depression
Fortney, J. C., Pyne, J. M., Edlund, M. J., Williams, D. K., Robinson, D. E., Mittal, D., & Henderson, K. L. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0201-9 · Cited by 315
Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial
Dobkin, R. D., Menza, M., Allen, L. A., Gara, M. A., Mark, M. H., Tiu, J., Bienfait, K. L., & Friedman, J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111669 · Cited by 310 · cited 3×
“(SD) was taken from baseline control data from prior work.(12) For the primary test of treatment differences in HAMD scores, controlling for baseline HAMD scores and demographic covariates, we considered 25 scenarios in which within-group SD ranged from 4.”
MethodResultSelf-citationTeleneurology and mobile technologies: the future of neurological care
Dorsey, E. R., Glidden, A. M., Holloway, M. R., Birbeck, G. L., & Schwamm, L. H. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2018.31 · Cited by 258 · cited 1×
“Telemedicine innovations offer a structural solution to this unyielding problem, allowing highly trained providers to offer specialized depression care to people with PD across a wide geographical area.(24) This randomized controlled trial (RCT) evaluated the efficacy of a tailored individual cognitive behavioral ther…”
BackgroundBarriers to mental health care utilization in Parkinson's disease
Dobkin, R. D., Rubino, J. T., Friedman, J., Allen, L. A., Gara, M. A., & Menza, M. (2013) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713481269 · Cited by 93 · cited 1×
“Additional systemic, persistent barriers to optimal depression treatment include a severe shortage of specialized mental health clinicians with adequate PD knowledge, and long travel distances to specialty care centers, further compounded by PD-specific transportation and mobility problems.(15) These treatment shortfa…”
BackgroundSelf-citationOehlberg, K., Barg, F. K., Brown, G. K., Taraborelli, D., Stern, M. B., & Weintraub, D. (2008) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708316862 · Cited by 53
Cited by
The neuropsychiatry of Parkinson's disease: advances and challenges
Weintraub, D., Aarsland, D., Chaudhuri, K. R., Dobkin, R. D., Leentjens, A. F., Rodriguez-Violante, M., & Schrag, A. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00330-6 · Cited by 450
Self-citationWang, M., Chen, H., Yang, F., Xu, X., & Li, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.06.057 · Cited by 25
Gandy, M., Woldhuis, T., Wu, W., Youssef, M., Bisby, M. A., Dear, B. F., Heriseanu, A. I., & Scott, A. J. (2024) · Psychological Medicine · doi:10.1017/s0033291724001995 · Cited by 20
“%) of the included PD trials were conducted by the same team, and reported large effects ( gs = 1.10 – 1.56) (Dobkin et al., 2011, 2020, 2021).”
BackgroundInfluentialA Systematic Review of Psychotherapy Approaches for Anxiety in Parkinson's Disease.
Roper, A., Pacas Fronza, G., Dobkin, R. D., Beaudreau, S. A., Mitchell, L. K., Pachana, N. A., Thangavelu, K., & Dissanayaka, N. N. (2024) · Clinical Gerontologist · doi:10.1080/07317115.2022.2074814 · Cited by 19
Self-citation
Metadata
- Authors
- Dobkin, R. D., Mann, S. L., Weintraub, D., Rodriguez, K. M., Miller, R. B., St. Hill, L., King, A., Gara, M. A., & Interian, A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2021-03-12
- Volume
- 36
- Issue
- 11
- Pages
- 2549-2558
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W3134712891
- Cited by
- 49
- References
- 13
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment. https://app.cochat.ai/papers/10.1002/mds.28548
- The paper
- Dobkin, R. D., Mann, S. L., Weintraub, D., Rodriguez, K. M., Miller, R. B., St. Hill, L., King, A., Gara, M. A., & Interian, A. (2021). Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment. Movement Disorders. https://doi.org/10.1002/mds.28548
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.